ALVOTECH revenue breakdown overview

ALVOTECH revenue for the last year amounted to 68.03 B ISK, the most of which — 67.71 B ISK — came from its highest performing source at the moment, Biosimilar Medicines, the year earlier bringing 12.46 B ISK. The greatest contribution to the revenue figure was made by United States — last year it brought ALVOTECH 37.75 B ISK.